×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
RSV anticorps
RSV
Reactivité: Respiratory Syncytial Virus (RSV)
ELISA, WB, IHC
Hôte: Chèvre
Polyclonal
unconjugated
Détail du produit anti-RSV anticorps
(cache)
Antigène
Tous les produits RSV
RSV
(Respiratory Syncytial Virus (RSV))
Reactivité
Toutes les réactivités sur RSV Anticorps
Respiratory Syncytial Virus (RSV)
Hôte
Toutes les hôtes sur RSV Anticorps
Chèvre
Clonalité
Toutes les clonalités sur RSV Anticorps
Polyclonal
Conjugué
Tous les conjugués à travers RSV Anticorps
Cet anticorp RSV est non-conjugé
Application
Tous les applications à travers RSV Anticorps.
ELISA, Western Blotting (WB), Immunohistochemistry (IHC)
Purification
purified
Pureté
> 95 % pure
Immunogène
RSV antibody was raised in goat using human RSV isolate as the immunogen.
Alternatives
(show)
Information d'application
(cache)
Indications d'application
Optimal conditions should be determined byt he investigator.
Restrictions
For Research Use only
Stockage
(cache)
Concentration
Lot specific
Buffer
Protein A purified in 10 mM PBS, pH 7.2, with 0.1 % NaN3.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Stock
4 °C/-20 °C
Stockage commentaire
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Références pour anticorps anti-RSV (ABIN285780)
(cache)
Geller, Andino, Frydman : "Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus. " dans: PLoS ONE , Vol. 8 , Issue 2 , pp. e56762 , (2013 ) (PubMed ).
Détails sur RSV
(cache)
Antigène
RSV
(Respiratory Syncytial Virus (RSV))
Autre désignation
RSV (RSV Produits )
Classe de substances
Virus
Sujet
Human respiratory syncytial virus (RSV) is a virus that causes respiratory tract infections. It is the major cause of lower respiratory tract infection and hospital visits during infancy and childhood. There is a prophylactic medication (not a vaccine) for premature (<35 Wks) infants and infants with congenital heart disease (CHD) or bronchopulmonary dysplasia (BPD). Treatment is limited to supportive care, including oxygen.
Vus récemment
(cache)